KANSAS CITY, Kan. — A list posted by the Food and Drug Administration shows that 13 Kansas City Metro hospitals and clinics — all on the Kansas side — have received medicine since May from the New England Compounding Center. That is the pharmacy associated with the huge, deadly meningitis outbreak.
Overall, there are more than 30 facilities in Kansas on the list. No facilities in Missouri were listed since New England Compounding is not a licensed distributor in the state.
Being on the list does not necessarily mean that the facility received tainted products — only that they received any product from the New England Compounding Center.
The list includes KU Med West and the University of Kansas Hospital, Menorah Medical Center, Olathe Medical Center, Overland Park Regional Medical Center and Shawnee Mission Medical Center.
To see a list of all Kansas facilities, click here.
To see a complete list, alphabetized by state, click here.
To see the same complete list with additional information that includes the specific products shipped, the quantities of product shipped, and the shipping date, click here.
The FDA has told the facilities to pull any product received from New England Compounding and to notify patients if they received an injectible drug. The FDA says patients who did are to remain vigilant for any signs and symptoms of infection.
The Chief Medical Officer at KU Hospital says it and KU Med West received four drugs altogether from New England Compounding and none is implicated in the meningitis outbreak. Still, the hospital is identifying roughly 250 patients who were treated with the drugs and notifying them. KU has established a hotline for its patients to call. That number is 913-588-1227. If you have questions, call your doctor or the facility that treated you.